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Abstract
© 2017 Sibarov, Bruneau, Antonov, Szepetowski, Burnashev and Giniatullin. Genetic variants of
the glutamate activated N-methyl-D-aspartate (NMDA) receptor (NMDAR) subunit GluN2A are
associated  with  the  hyperexcitable  states  manifested  by  epileptic  seizures  and  interictal
discharges in patients with disorders of the epilepsy-aphasia spectrum (EAS). The variants found
in sporadic cases and families are of different types and include microdeletions encompassing
the corresponding GRIN2A gene as well as nonsense, splice-site and missense GRIN2A defects.
They are located at different functional domains of GluN2A and no clear genotype-phenotype
correlation has emerged yet. Moreover, GluN2A variants may be associated with phenotypic
pleiotropy. Deciphering the consequences of pathogenic GRIN2A variants would surely help in
better understanding of the underlying mechanisms. This emphasizes the need for functional
studies to unravel the basic functional properties of each specific NMDAR variant. In the present
study, we have used patch-clamp recordings to evaluate kinetic changes of mutant NMDARs
reconstituted after co-transfection of cultured cells with the appropriate expression vectors.
Three previously identified missense variants found in patients or families with disorders of the
EAS  and  situated  in  the  N-terminal  domain  (p.Ile184Ser)  or  in  the  ligand-binding  domain
(p.Arg518His  and  p.Ala716Thr)  of  GluN2A  were  studied  in  both  the  homozygous  and
heterozygous conditions. Relative surface expression and current amplitude were significantly
reduced for NMDARs composed of mutant p.Ile184Ser and p.Arg518His, but not p.Ala716His, as
compared with wild-type (WT) NMDARs. Amplitude of whole-cell currents was still drastically
decreased when WT and mutant p.Arg518His-GluN2A subunits were co-expressed, suggesting a
dominant-negative  mechanism.  Activation  times  were  significantly  decreased  in  both
homozygous and heterozygous conditions for the two p.Ile184Ser and p.Arg518His variants, but
not  for  p.Ala716His.  Deactivation also significantly  increased for  p.Ile184Ser variant  in  the
homozygous but not the heterozygous state while it was increased for p.Arg518His in both
states. Our data indicate that p.Ile184Ser and p.Arg518His GluN2A variants both impacted on
NMDAR function, albeit differently, whereas p.Ala716His did not significantly influence NMDAR
kinetics, hence partly questioning its direct and strong pathogenic role. This study brings new
insights into the functional impact that GRIN2A variants might have on NMDAR kinetics, and
provides  a  mechanistic  explanation  for  the  neurological  manifestations  seen  in  the
corresponding  human  spectrum  of  disorders.
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